The American Diabetes Association stated in their 2025 guidelines that retinopathy status should be assessed among patients with diabetes who undergo an intensification of glucose-lowering therapies, including glucagon-like peptide-1 receptors, …
Copyright MatchingDonors.com©️ 2025 All rights reserved.